138 related articles for article (PubMed ID: 23098770)
1. Gene transfer of human CD40Ig does not prevent rejection in a non-human primate kidney allotransplantation model.
Angin M; Poirier N; Dilek N; Le Guiner C; Toromanoff A; Blancher A; Cherel Y; Deschamps JY; Tillou X; Renaudin K; Minault D; Hervouet J; Blancho G; Vanhove B; Anegon I; Le Mauff B
Transpl Immunol; 2012 Dec; 27(4):139-45. PubMed ID: 23098770
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Jul; 80(2):255-63. PubMed ID: 16041272
[TBL] [Abstract][Full Text] [Related]
4. Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model.
Kanaya K; Tsuchida Y; Inobe M; Murakami M; Hirose T; Kon S; Kawaguchi S; Wada T; Yamashita T; Ishii S; Uede T
Transplantation; 2003 Feb; 75(3):275-81. PubMed ID: 12589145
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients.
Guillonneau C; Séveno C; Dugast AS; Li XL; Renaudin K; Haspot F; Usal C; Veziers J; Anegon I; Vanhove B
J Immunol; 2007 Dec; 179(12):8164-71. PubMed ID: 18056359
[TBL] [Abstract][Full Text] [Related]
6. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
Guillot C; Guillonneau C; Mathieu P; Gerdes CA; Ménoret S; Braudeau C; Tesson L; Renaudin K; Castro MG; Löwenstein PR; Anegon I
J Immunol; 2002 Feb; 168(4):1600-9. PubMed ID: 11823487
[TBL] [Abstract][Full Text] [Related]
7. In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection.
Ripoll E; Pluvinet R; Torras J; Olivar R; Vidal A; Franquesa M; Cassis L; Cruzado JM; Bestard O; Grinyó JM; Aran JM; Herrero-Fresneda I
Gene Ther; 2011 Oct; 18(10):945-52. PubMed ID: 21472009
[TBL] [Abstract][Full Text] [Related]
8. New possibilities of therapeutic interventions in transplantation.
Magott-Procelewska M; Klinger M
Ann Transplant; 2004; 9(3):19-24. PubMed ID: 15759542
[TBL] [Abstract][Full Text] [Related]
9. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade.
Jiang Z; Schiedner G; van Rooijen N; Liu CC; Kochanek S; Clemens PR
Mol Ther; 2004 Oct; 10(4):688-96. PubMed ID: 15451453
[TBL] [Abstract][Full Text] [Related]
10. Prolongation of renal allograft survival in rats by replication-defective recombinant adenovirus-mediated coexpression of CD40L and CTLA4Ig.
Tian PX; Li ZL; Zhang YS; Xue WJ; Wu J
Transplant Proc; 2006 Jun; 38(5):1634-7. PubMed ID: 16797372
[TBL] [Abstract][Full Text] [Related]
11. Combined costimulation blockade prevents rejection of allogeneic islets in mice.
Malm H; Påhlman C; Veress B; Corbascio M; Ekberg H
Scand J Immunol; 2006 Oct; 64(4):398-403. PubMed ID: 16970681
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated CTLA4Ig or CD40Ig gene transfer delays pancreatic islet rejection in a rat-to-mouse xenotransplantation model after systemic but not local expression.
Potiron N; Chagneau C; Boeffard F; Soulillou JP; Anegon I; Le Mauff B
Cell Transplant; 2005; 14(5):263-75. PubMed ID: 16052908
[TBL] [Abstract][Full Text] [Related]
13. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.
Haanstra KG; Ringers J; Sick EA; Ramdien-Murli S; Kuhn EM; Boon L; Jonker M
Transplantation; 2003 Mar; 75(5):637-43. PubMed ID: 12640302
[TBL] [Abstract][Full Text] [Related]
14. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
[TBL] [Abstract][Full Text] [Related]
15. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
Vierboom MP; Ossevoort M; Sick EA; Haanstra K; Jonker M
Transpl Immunol; 2003; 11(2):215-22. PubMed ID: 12799206
[TBL] [Abstract][Full Text] [Related]
16. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.
Zahorsky-Reeves JL; Kearns-Jonker MK; Lam TT; Jackson JR; Morris RE; Starnes VA; Cramer DV
Xenotransplantation; 2007 Mar; 14(2):135-44. PubMed ID: 17381688
[TBL] [Abstract][Full Text] [Related]
17. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy.
Wu JQ; Zhao WH; Li Y; Zhu B; Yin KS
Virology; 2007 Nov; 368(2):309-16. PubMed ID: 17675129
[TBL] [Abstract][Full Text] [Related]
19. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
20. CD40-ligand in primate cardiac allograft and viral immunity.
Pierson RN; Crowe JE; Pfeiffer S; Atkinson J; Azimzadeh A; Miller GG
Immunol Res; 2001; 23(2-3):253-62. PubMed ID: 11444390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]